NCT00742508 A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure Status COMPLETED Phase PHASE1
NCT00742261 A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00742209 Prevention Study in Adult Patients Suffering From Migraine Headaches Status COMPLETED Phase PHASE2
NCT00742144 Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE1
NCT00742131 A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00741767 The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD Status WITHDRAWN Phase NA
NCT00740064 Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects Status UNKNOWN Phase PHASE4
NCT00738023 Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00736801 Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma Status COMPLETED Phase NA
NCT00734032 A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients Status COMPLETED Phase PHASE2
NCT00733980 A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT00733785 PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00733577 A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing. Status COMPLETED Phase PHASE1
NCT00733551 Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. Status COMPLETED Phase PHASE1
NCT00733174 Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance Status UNKNOWN Phase PHASE4
NCT00732940 Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE) Status TERMINATED Phase PHASE2
NCT00732472 A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days Status COMPLETED Phase PHASE2
NCT00732420 Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00731822 A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2